InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc.

ARTV Clue Score30
United States Fiscal year ends December CIK 0001817241 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
31 Jul 2026
Director
Buy indirect
24,944
$9.93
$247.69K
Ra Capital Management, L.p.
29 Jul 2026
Director
Buy indirect
20,824
$9.99
$208.03K
Ra Capital Management, L.p.
24 Jul 2026
Director
Buy indirect
41,319
$9.99
$412.78K
Ra Capital Management, L.p.
23 Jul 2026
Director
Buy indirect
59,880
$9.96
$596.40K
Ra Capital Management, L.p.
22 Jul 2026
Director
Buy indirect
84,124
$9.93
$835.35K
Ra Capital Management, L.p.
21 Jul 2026
Director
Buy indirect
120,582
$9.55
$1.15M
Ra Capital Management, L.p.
17 Jul 2026
Director
Buy indirect
7,882
$8.95
$70.54K
Ra Capital Management, L.p.
16 Jul 2026
Director
Buy indirect
152,472
$8.93
$1.36M
Ra Capital Management, L.p.
13 Jul 2026
Director
Buy indirect
6,552
$8.94
$58.57K
Ra Capital Management, L.p.
10 Jul 2026
Director
Buy indirect
15,102
$8.97
$135.46K
Ra Capital Management, L.p.
26 Jun 2026
Director
Buy indirect
1,876
$8.98
$16.85K
Ra Capital Management, L.p.
25 Jun 2026
Director
Buy indirect
31,000
$8.88
$275.28K
Ra Capital Management, L.p.
16 Jun 2026
Director
Buy indirect
124,893
$8.89
$1.11M
Ra Capital Management, L.p.
15 Jun 2026
Director
Buy indirect
15,414
$8.99
$138.57K
Ra Capital Management, L.p.
12 Jun 2026
Director
Buy indirect
391,019
$8.57
$3.35M
Ra Capital Management, L.p.
11 Jun 2026
Director
Buy indirect
548,580
$7.91
$4.34M
Ra Capital Management, L.p.
10 Jun 2026
Director
Buy indirect
103
$7.00
$721.00
Ra Capital Management, L.p.
9 Jun 2026
Director
Buy indirect
479,039
$6.91
$3.31M
Ra Capital Management, L.p.
11 May 2026
Director
Buy indirect
6,510,416
$11.52
$75.00M
GC Corp.
11 May 2026
10% owner
Buy indirect
347,222
$11.52
$4.00M
GC Corp.
11 May 2026
10% owner
Buy
1,085,069
$11.52
$12.50M
Show all 44 transactions →

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 2,534,096
History held since 22 Jul 2024